Sign in

    Jessica Fife

    Research Analyst at JPMorgan Chase & Co.

    Jessica Fife is an analyst at JPMorgan Chase & Co., but based on available public data, there are no verifiable details regarding her exact job title, covered companies, track record, or professional credentials. No credible sources or professional profiles list her coverage of specific firms, published performance metrics, or success rates. There is also no documented career timeline, prior employment history, or record of securities licenses for Jessica Fife at JPMorgan. Comprehensive details about her professional background or achievements could not be found in public sources.

    Jessica Fife's questions to Crinetics Pharmaceuticals (CRNX) leadership

    Jessica Fife's questions to Crinetics Pharmaceuticals (CRNX) leadership • Q2 2025

    Question

    An analyst on behalf of Jessica Fife of JPMorgan Chase & Co. asked about the company's comfort level with current consensus sales estimates for the upcoming paltusotine launch.

    Answer

    CFO Tobin Schilke stated that it is not typical or prudent for the company to comment on consensus estimates at this stage, as they have not provided official guidance. He reiterated confidence in the launch preparations and the progress being made with the FDA.

    Ask Fintool Equity Research AI